Access to Digital Health Services Transforming Physicians' Approach to Patient Care in Canada

TORONTO, Dec. 10, 2018 /CNW/ - Physician access to connected health information in Canada is now high, yet Canadians' access to virtual care services is limited, according to a new study conducted by Canada Health Infoway (Infoway).

The 2018 Canadian Physician Survey (2018 CPS) is the first national survey of physicians exclusively focused on the use of digital health technologies in practice. It was developed and conducted in collaboration with national physician associations, the Canadian Institute for Health Information (CIHI) and the Canadian Medical Directory (Scotts Directories).

Close to 1,400 practising physicians completed the survey, which covers topics such as electronic medical record (EMR) adoption and use, access to connected health information and patient access to virtual care services.

According to the 2018 CPS, four per cent of primary care physicians and nine per cent of specialists say that patients in their practice can visit with them online via a face-to-face virtual visit — a digital service that interests more than 40 per cent of Canadians, according to another recent Infoway survey.

The 2018 CPS also found that:

84 per cent of primary care physicians and 89 per cent of specialists report that they have access to connected health information from care settings outside their main practice.
82 per cent of primary care physicians and 77 per cent of specialists say they provide more efficient care with electronic records.
31 per cent of primary care physicians report optimized EMR use.
38 per cent of primary care physicians and 47 per cent of specialist physicians currently offer patients at least one virtual care or e-service. This is mainly driven by practices/clinics becoming more accessible to patients via email communication (24 per cent of primary care and 40 per cent of specialist practices/clinics), but the majority of physicians do not spend any time during their day electronically communicating with patients.

"Canadians continue to tell us that they want access to digitally-enabled health services, including the ability to email their doctors and book appointments online," said Michael Green, President & CEO, Infoway. "Canadians deserve modern, 21^st century health services, and our goal is to provide them with access to digital services that will improve their care experiences and health outcomes."

Download the 2018 Canadian Physician Survey.

About Canada Health Infoway

Canada Health Infoway helps to improve the health of Canadians by working with partners to accelerate the development, adoption and effective use of digital health across Canada. Through our investments, we help deliver better quality and access to care and more efficient delivery of health services for patients and clinicians. Infoway is an independent, not-for-profit organization funded by the federal government.

Media inquiries:

Karen Schmidt
Director, Corporate Communications
Canada Health Infoway
Tel: (416) 595-3167
Email Us
Follow @Infoway

SOURCE Canada Health Infoway

Legal cannabis industry’s crypto tax breakthrough

Cannabis retailers empowered to adhere to tax laws thanks to new payments platform partnership

New York, December 10, 2018 - The legal US cannabis retail industry took another step towards mainstream business compliance today – as cannabis retailers became empowered to track all transactional data related to taxes, gains and losses.

Cryptocurrencies have proved a popular form of payment at cannabis shops in the 33 US states where sales are now legal – but crypto tax laws remain vague, and it has proved difficult for retailers to produce accurate and compliant accounts.

But the process has become far more simple and straightforward, thanks to the integration of NODE40’s pioneering cryptocurrency accounting and tax platform into Alt Thirty Six – the blockchain payments platform designed for the cannabis industry.

The partnership enables retailers to stay tax compliant and within the law, while the IRS will be helped to receive the taxes it is due from an exponentially expanding industry.

Announcing the partnership today, Perry Woodin, Chief Executive Officer of NODE40, said: “With the many cryptocurrency transactions Alt Thirty Six facilitates, our solution will make it simple for them to maintain accurate reporting and sound compliance. With this partnership, NODE40’s Balance platform is expanding its reach to serve enterprise clients, in addition to individual cryptocurrency holders.”

Alt Thirty Six uses Dash digital currency as an alternative to cash, making payments faster, more secure and less expensive to both the merchant and the consumer.

NODE40’s Balance platform will help customers receive and process transactional data related to Dash payments, track sales tax and income valuations, verify blockchain transactions and report cryptocurrency gains and losses, and deliver summary-level information from processed data.

Alt Thirty Six CEO and Co-Founder Ken Ramirez said: “NODE40 values top-notch technology, and it’s clear that their leadership team understands our mission to take the growing cannabis industry completely cashless.”

“We believe that digital payments are the future of global commerce, and we are confident that the combination of blockchain technology and Dash digital currency will revolutionize the payments industry."

Balance is a Software-as-a-Service (Saas) platform that offers both enterprise and individual cryptocurrency users the ability to generate fiat denominated ledgers by analyzing the blockchain to identify capital gains and losses.

Users can upload data from various hardware or software wallets, as well as exchanges like Coinbase, GDAX, Gemini and Bittrex. When a user authorizes read access to their transaction history, Balance provides both a high level and detailed summary, including date, time, transaction type, short-term or long-term gains, and price differential.

Once the gains and losses are calculated, the service automatically details the information on a worksheet that can be shared with a CPA to file at tax time. For on-blockchain transactions, Balance uses specific identification, the only methodology in-line with IRS guidance and AICPA recommendations.

About NODE40

NODE40 is a financial services provider for individuals and businesses that have interacted with cryptocurrency. NODE40’s flagship product, Balance, is a robust cryptocurrency tax calculation software that integrates directly with major cryptocurrency exchanges and custodial wallets. Members of the blockchain community transacting in, trading, or mining digital currency, have triggered taxable events and may be unaware of how to properly disclose these transactions to the government. For more information, visit https://www.node40.com/balance/

About Alt Thirty Six

Alt Thirty Six believes simplicity is the ultimate form of sophistication. their fully-integrated digital payments solution solves all the problems associated with Bitcoin, traditional payments, and banking solutions. As companies struggle to minimize the cost of accepting payments, they completely eliminate the fees charged by processors and banks. They see the potential for digital currency to revolutionize financial services, making commerce faster, more secure, and less expensive. For more information, visit www.altthirtysix.com

Tissue Regeneration Therapeutics and RoosterBio Inc. Form Strategic Alliance to Commercialize Umbilical Cord Tissue Cell Technology

TORONTO, Dec. 10, 2018 /CNW/ - Today Tissue Regeneration Therapeutics Inc. (TRT) and RoosterBio Inc. (RBI) announce an important strategic alliance to advance their shared goal of accelerating the development of the Regenerative Medicine and Cellular Therapy fields. This collaboration will be focused on applying RoosterBio's unique scale-up bioprocess systems to TRT's core technology around human umbilical cord perivascular cells (HUCPVCs). Together, it is anticipated that these technology platforms will establish a new level of perivascular stromal/stem cell manufacturing productivity, thus creating newfound efficiencies in Regenerative Medicine.

"RoosterBio have established themselves as leaders in hMSC bioprocess systems, and we are enthusiastic to apply their scalable, cGMP production platforms to our patented umbilical cord perivascular cellular (TXP) technology. We believe that our TXP technology has unique advantages over other mesenchymal cell sources, and leveraging RoosterBio's scalable manufacturing platforms will accelerate our therapeutic programs. Overall, this strategic alliance will have far reaching implications in the fields of Regenerative Medicine and Cellular Therapy." said John E. Davies, DSc, President & CEO of TRT.

Margot Connor, RoosterBio's CEO states "Tissue Regeneration Therapeutics have established themselves as leaders in cord tissue perivascular cells, and we are excited to collaborate to help drive cell manufacturing productivity within their unique technology platform." She adds, "We've experienced great collaboration with TRT over the last few years, and we look forward to deepening our relationship with them."

About Tissue Regeneration Therapeutics Inc.:
TRT is a Canadian Controlled Private Corporation (CCPC) with a focus on the commercial development of their patented Human Umbilical Cord PeriVascular Cell (HUCPVC) technology platforms that include culture expanded cells (TXP) and engineered cells (eTXP). The latter are designed for specific unmet needs, in addition to the constitutive advantages of TXP, by the engineered secretion of cytokines, growth factors or monoclonal antibodies for targeted therapies. TRT is the first company in the world to have issued and allowed patents in the USA, Europe and Australasia, for extraction of these unique cells from umbilical cord tissue, and their gene engineering. Additional information is available at http://www.verypowerfulbiology.com

About RoosterBio, Inc.:
RoosterBio, Inc. is a privately held stem cell tools and technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio's products are high volume, affordable, and well-characterized adult hMSCs paired with highly engineered bioprocess media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio and adult stem cells, please visit www.roosterbio.com, follow on twitter (@RoosterBio), or read the blog "Democratizing Cell Technologies" (www.roosterbio.blogspot.com).

SOURCE Tissue Regeneration Therapeutics Inc.

WHAT ARE PHTHALATES?

How Can These Culprits in Plastics Contribute to Weight Gain?

By Eddie Fatakhov M.D. (a.k.a. Dr. Fat-Off)

Phthalates, not to be confused with Pilates exercises, are semi volatile organic compounds found in plastics because they make them soft and flexible.

Though commercially useful, these chemicals can easily leach out of plastics to contaminate our food, water supply, and even the air we breathe. This is when phthalates become a real problem

How do phthalates cause problems?

Phthalates are also endocrine disruptors. Your endocrine system is made up a network of glands (thyroid gland, ovaries, etc.) and the hormones (insulin, estrogen, etc.) they produce. These hormones are used to communicate with cells and tissues to regulate many functions – this can result in insulin resistance, obesity and thyroid disease.

Phthalates, once in the body, disrupt the endocrine system in the following negative ways:

They mimic, or partly mimic, our naturally occurring hormones
When they mimic they bind to our hormone receptors so that our naturally occurring hormones can’t
This bonding causes our bodies to have irregular physical responses since the hormones that are supposed to attach to our receptors can’t

Once our natural hormone function is disrupted our bodies can’t regulate our systems efficiently.

How to avoid phthalates?

In order to limit your phthalate exposure, think fresh and limit your plastic usage.

Because many phthalates can be found in food packaging, going fresh at the grocery store can have a huge impact on your overall exposure.

Buy fresh fruit and vegetables.

Though eating organic is useful in eliminating an array of phthalates it can also have a noticeable impact on your grocery budget. Non organic fruit and vegetables are okay too. If organic produce isn’t fiscally feasible, just make sure to give all your non organic fruit and vegetables a good water wash before cutting or biting into them.

Buy intact foods.

If you decrease the processing (cutting, changing, repackaging etc.) of the food you buy you can actually decrease some phthalates. EXAMPLE: Buy a whole chicken vs. chicken tenders

Store food in glass or paper containers.

Not only do glass containers tend to last longer and stand up to more washing than their plastic alternatives, they also take many phthalates out of the picture.

Filter your water.

Buying a simple water filtration system can make a difference. While most tap water is considered safe to drink there may be trace elements of phthalates present that a simple water filter can remove.

Keep plastic out of the microwave.

We understand that eliminating all plastic may not be possible but the process of microwaving a plastic container can actually release any phthalates it contains. This is how phthalates can get into your food.

Choose your plastics wisely.

Plastics marked with any of the following recycling codes are potentially safe: PET, HDPE, LDPE and POLYPROPYLENE. We say “potentially” since current regulations do not require manufacturers to label their material. To be completely safe we recommend sticking to glass, paper, stainless steel, and wood alternatives.

If you would like more information on ways to deal with phthalates, please contact The Center for Internal and Integrative Medicine to schedule a consultation with Dr. Fatakhov.

ABOUT DR. FAT-OFF…

Eddie Fatakhov, M.D., a.k.a. Dr. Fat-off, is a Board-Certified Physician, Nutritionist, and Best-Selling Author of "The Doctors' Clinic-30 Program. His latest book is “Dr. Fat-Off Simple Life-Long Weight-Loss Solutions.”

Email: eddie@drfatakhov.com

Office: 404-836-9906
Website: www.eddiefatakhovmd.com
Facebook: https://www.facebook.com/fatakhov

Instagram: http://instagram.com/eddiefatakhovmd/

Premier Health Announces Binding LOI to Acquire Operating Pharmacy

For the fiscal year 2017/18, the pharmacy has revenues of approximately $1MM and Adjusted EBITDA^[¹^] of approximately 30%
Advances Premier's long-term strategy of growing its business in each of the major verticals of primary care

VANCOUVER, Dec. 10, 2018 /CNW/ - Premier Health Group (CSE: PHGI) (OTCQB: PHGRF) (Frankfurt: 6PH) (the "Company" or "Premier Health"), a Company focused on developing innovative approaches that combine human skill based expertise with emerging technologies for the healthcare industry, is pleased to announce that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent ("LOI") to acquire a Vancouver, British Columbia based pharmacy. The Company expects the acquisition to close in or about Q1-19.

"We are excited for this opportunity to acquire our first pharmacy, and thereafter being able to prepare and deliver prescription and non-prescription pharmaceuticals and other health products to patients. In doing so, the pharmacist will play an integral role in our team-based patient centric model," said Dr. Essam Hamza, CEO of Premier. "Premier has engaged with patients, pharmacies and technology providers to not only introduce pharmacy services as a component of our comprehensive telemedicine app, but also to explore and implement efficiencies in fill and fulfillment."

Under the terms of the LOI, the total consideration payable by Premier is $1,350,000, which will be paid as follows: (i) $200,000 deposit paid on signing of the LOI, (ii) $350,000 due on signing of a definitive agreement, (iii) $650,000 due on closing, (iii) $150,000 due six (6) months after closing.

The acquisition is subject to customary closing conditions, including execution of a definitive acquisition agreement and receipt of any required regulatory and stock exchange approvals.

The Company continues to evaluate additional pharmacy acquisitions and/or partnerships, which include bricks and mortar locations and strategic new retail opportunities. Additionally, the Company has engaged with healthcare technology providers and expects to provide further updates on its HealthVue app and other technology initiatives in the coming weeks.

Footnote:

This news release contains references to Adjusted EBITDA from continuing operations, which is a non-IFRS metric. Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization, adjusted for non-recurring distributions to current owners. Premier uses EBITDA as it is a common measure used to assess profitability before the impact of different financing methods, income taxes, depreciation and impairment of capital assets and amortization of intangible assets. Premier believes that investors and financial analysts also use EBITDA to evaluate financial performance. EBITDA is not a measure of financial performance under IFRS and should not be considered as an alternative to operating income or any other measure of financial performance presented in accordance with IFRS. EBITDA excludes some, but not all, items that affect operating income.

ON BEHALF OF THE BOARD OF DIRECTORS
"Dr. Essam Hamza, MD"
Chief Executive Officer

About Premier Health

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are developing innovative health care approaches that combine human skill based expertise with emerging technologies, with the goal of setting the gold standard for services in locations of interest worldwide. Premier Health's subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have an ecosystem of over 100,000 active patients and have plans to rapidly increase that number both domestically and internationally. The HealthVue team has a strong track record of successfully creating value in healthcare and technology enterprises. The Management team has deep clinical, financial and operational expertise and a passion for improving healthcare for all patients.

Cautionary Statements

This news release contains forward-looking statements that are based on Premier Health's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the acquisition of the pharmacy, including the timing thereof, and its plan to acquire additional pharmacies in the future. Although Premier Health believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Premier Health undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

This news release contains future-oriented financial information and financial outlook information (collectively, "FOFI") about Premier's prospective results of operations, including revenue and EBITDA, all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs. FOFI contained in this news release was made as of the date of this news release and was provided for the purpose of providing further information about Premier's future business operations. Premier disclaims any intention or obligation to update or revise any FOFI contained in this news release, whether as a result of new information, future events or otherwise, except as required by securities law. Investors are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.

Non-GAAP Financial Measures

This news release contains non-generally accepted accounting principles ("GAAP") financial measures. The non-GAAP financial measures in this news release include EBITDA, or earnings before interest, taxes, depreciation and amortization. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Premier utilizes both GAAP and non-GAAP financial measures to assess what it believes to be its core operating performance and to evaluate and manage its internal business and assist in making financial operating decisions. Premier believes that the inclusion of non-GAAP financial measures, together with GAAP measures, provides investors with an alternative presentation useful to investors' understanding of Premier's core operating results and trends

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Premier Health Group Inc.

Genetic study of epilepsy points to potential new therapies

RCSI researchers play key role in international collaboration

DUBLIN, Dec. 10, 2018: The largest study of its kind, led by international researchers including scientists at RCSI (Royal College of Surgeons in Ireland), has discovered 11 new genes associated with epilepsy.

The research is published in today’s issue of Nature Communications (DOI: 10.1038/s41467-018-07524-z). It greatly advances knowledge of the underlying biological causes of epilepsy and may inform the development of new treatments for the condition.

Researchers compared the DNA of more than 15,000 people with epilepsy to the DNA of 30,000 people without epilepsy. This has created a better understanding of genetic factors that contribute to the most common forms of this condition, and the results tripled the number of known genetic associations for epilepsy and implicated 11 new genes.

The researchers found that the majority of current anti-epileptic drugs directly target one or more of the associated genes and identified an additional 166 drugs that do the same. These drugs are promising new candidates for epilepsy therapy as they directly target the genetic basis of the disease.

“This work illustrates the power of scientists collaborating across countries and continents. Discovering these new genes for epilepsy provides important information towards novel treatments for the condition. This is another important step on the road towards curing the epilepsies,” said Gianpiero Cavalleri, Associate Professor at the RCSI Department of Molecular and Cellular Therapeutics and Deputy Director of the FutureNeuro SFI Research Centre.

"In addition to the biological insights provided by the findings, this study will encourage researchers to develop personalised and precision therapies for patients with difficult and complex epilepsy. This will provide better seizure control and will enable improved quality of life for patients and families," said consultant neurologist Norman Delanty, Associate Professor at RCSI, FutureNeuro and Beaumont Hospital.

“We have appreciated for some time that genetics plays an important role in epilepsy, however, until now, relatively little was known about the specific genes responsible for the most common forms of the disorder. Identifying the genes that cause epilepsy is particularly important when we consider that a third of the 65 million patients worldwide will not become seizure free using current treatment options,” said Dr Colin Doherty, National Clinical Lead for Epilepsy and a Principal Investigator at the FutureNeuro Centre.

Over 150 researchers, based across Europe, Australia, Asia, South America and North America, carried out the research. They worked together as part of the International League Against Epilepsy (ILAE) Consortium on Complex Epilepsies. The ILAE Consortium was formed by researchers in 2010, recognising that the complexity of genetic and environmental factors underlying epilepsy would require research across massive datasets, and therefore unprecedented collaboration on an international scale. Science Foundation Ireland (SFI) part-funded the study.

“Conducting a study of this size and scope is an incredible accomplishment that RCSI and FutureNeuro were delighted to help lead. We look forward to building on the results of this study and strengthening international collaborations,” said Professor Cavalleri.

“The next steps would be expanding these results in an even larger sample, which is underway, and then drilling down on specific groups of patients and the genes that influence their type of epilepsy to trial new therapies,” Professor Sam Berkovic, University of Melbourne.

ENDS

About RCSI

RCSI is ranked among the top 250 (top 2%) of universities worldwide in the Times Higher Education World University Rankings (2019) and its research is ranked first in Ireland for citations. It is an international not-for-profit health sciences institution, with its headquarters in Dublin, focused on education and research to drive improvements in human health worldwide. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.

About ILAE

The International League Against Epilepsy (ILAE) was founded in 1909 and is an organisation of more than 100 national chapters.

The goals of the ILAE are:

To advance and disseminate knowledge about epilepsy
To promote research, education and training
To improve services and care for patients, especially by prevention, diagnosis and treatment

Are You Losing Your Balance And You Don’t Know Why?

Balance Disorders Are Common, But It’s Important

To Learn What’s Causing Them, Orthopedist Says

We’ve all lost our balance – slipping on ice, getting knocked down in a sport, tripping over a toy, or perhaps from feeling dizzy. But sometimes body imbalance is less obvious, lurking inside while we move freely about, and the causes may indicate long-term problems if left unresolved.

It’s been estimated that over 30 million Americans have some type of balancedisorder. There are various ways to test for it, and Dr. Victor Romano, an orthopedist, says doing so increases the chances of finding the source of the problem and determining non-surgical solutions.

“When your body is out of balance, you will begin to experience a myriad of problems,” says Romano (www.romanomd.com), author of Finding The Source: Maximizing Your Results – With and Without Orthopaedic Surgery. “A loss of balance indicates something is wrong internally. It’s a clue to look further.”

Dr. Romano, who uses a type of balance and reflex testing called Autonomic Motor Nerve Reflex Testing (AMNRT), can discuss for your listeners how balance is related to the health of neuromuscular systems and how to keep the body better aligned.

Discussion Questions

How does AMNRT reflex testing differ from more conventional approaches?
You mention in your book how easily you could push over some big, strong football players because of their balance issues. How was that possible?
Why is it that where a patient is experiencing orthopedic pain may not be the actual underlying location or source of the problem?
Some people are fine with their balance until they close their eyes and try to stand still. What problem does that indicate?

About Dr. Victor Romano

Dr. Victor Romano (www.romanomd.com) is an orthopedic surgeon in Oak Park, Ill.,

and the author of Finding The Source: Maximizing Your Results – With and Without

Orthopaedic Surgery. He is board-certified in orthopedics and sports medicine with

over 25 years of experience in the field. He graduated cum laude from the University of

Notre Dame and completed medical school at the University of Loyola-Chicago.

Uncovering Our Natural Strengths To Live Up To Our Fullest Potential

Discovery Bay, CA, December 8, 2018—For everyone's holiday list this year, the gift that keeps on giving is The Gifted Journey: Five Transformative Steps to Uncovering Your Unique Path by Gallup-certified strengths coach Stephanie Moore. Moore's proven steps to finding our own path to living a more purposeful, joy-filled life are based on decades of personal experience in career development.

Moore stays focused on all things positive, as she introduces her actionable five-step process designed to help readers Discover, Discern, Dream, Design and Do what they were always meant to do based upon their natural strengths—their gifts.

Each of the five steps contains exploratory exercises that walk readers through personal reflection and the gathering of objective perspectives from trusted colleagues and friends. The result is a blend of self assessments and external input that makes The Gifted Journey uniquely adaptable to the needs of each individual.

Along the way, Moore shares professional and personal anecdotes to help drive home her impactful message that through embracing our authentic skill sets, we can move toward more promising futures with renewed passion and enthusiasm.

The Gifted Journey is for anyone questioning their direction in life, including those about to apply for colleges, those just starting out in their careers, downsizing statistics, or those who are simply unhappy with their current path and need some course correction. Each of these situations can be a powerful catalyst to seeking change, and the five steps in The Gifted Journey can help readers uncover their gifts and put them to work.

Stephanie Moore is a Gallup-certified strengths coach with more than two decades of experience in leadership development, career consulting and executive coaching. As a strengths-based practitioner, she has used her unique blend of expertise, passion and spirituality to help thousands of people discover more fulfilling and rewarding career paths. She has designed and currently delivers the highly successful and comprehensive development courses, Strengths-Based Development and Strengths-Based Teams, to organizations, universities and associations across the globe.

She launched The Moore Group, Inc., in 2000 and cofounded the nonprofit Catholic Strengths and Engagement Community in 2008. She is a native of Northern California and holds a bachelor's degree in psychology from St. Mary's College in Moraga, California. She is also a graduate of the School for Pastoral Ministry through the Diocese of Oakland. She is currently developing a series of retreats and workshops that follow The Gifted Journey process.

For more information, please visit www.thegiftedjourney.com.

The Gifted Journey: Five Transformative Steps to Uncovering Your Unique Path
Inspired Forever Book Publishing
Released: September 2018
ISBN-13: 9780999625880
ISBN-13: 9780999625897
Available from Amazon.com and other e-book retailers

Reviews:

Fredrick Gilbert, Ph.D., Let'er Rip Productions – "… Whether you are starting out life in high school or making major mid-life changes this book is the tool belt that will help you construct your future. It is all here: self-assessment tools; exercises to understand your strengths and passions; ways to evaluate where you fit into the world of work. Stephanie's writing style is so accessible. She feels like an old friend who is being straight with you by letting you inside her own life-changing struggles. … If you are struggling to understand how your past can chart your future happiness, read this book. Do the exercises. Put it into action. Then write a thank you note to Stephanie.”

Mary McGlynn, president and VP of learning, development and research, PowerSpeaking, Inc. – "Stephanie Moore's The Gifted Journey serves as your personal archaeologist. As you proactively become a searcher of clues, a seeker of patterns, and a creator for your own fulfilled future, you find the path to your own career satisfaction. With assessments, tools, and exercises, your story unfolds in a magical way.”

Jo Ann Miller, OSF Strengths Development Center, former 40-year Gallup employee – "The Gifted Journey, is an amazing contribution! As Stephanie shares from her own gifted journey, she will lead you to discover your own 'conscious competence' at whatever time in your life you meet her invitation. When individuals truly work in their 'strengths zone,' it feels 'just right to them and others like it too.' One can feel Stephanie's joy and pleasure—not only in her own life's multifaceted talent discoveries, but in her day-to-day experience of living them out. Walk with Stephanie through her 5-D strategy for life's journey. Find a GIFT on every page as you 'learn, love and live' your gifted journey.”

Rick Fersch, former president and CEO of Eddie Bauer – "The 'WOW' moment in this book is when you recognize that each day is a gift waiting to be opened and discovered. I strongly subscribe to Stephanie's thesis that our life journey should be used to uncover and emphasize our strengths—and to build upon these gifts for a more fulfilling and promising future. Executing this 5 stage process will allow us to live the life that was always intended just for us. I was a business leader for over 30 years, and as president and CEO of Eddie Bauer, I suffered a life threatening stroke that changed my world and led me to embrace these stages. Using this process allowed me to discern how best to change my course, and how to apply my gifts to the faith world as Executive Director of Stewardship and Development at the Archdiocese of Seattle. Through living my own life journey, I can readily embrace and endorse Stephanie's well laid out process. It is both refreshing and innovative—building on widely known and successful concepts for helping to find your true self. Her unique and easy to read format allows you to execute action points that help support your master life plan.”

Rock Solid Research On How To Prevent Dementia And Maintain A Healthy Brain

Chattanooga, TN, Dec. 7, 2018 ― Dr. Timothy R. Jennings speaks expertly on a subject that concerns over 5.5 million people across the nation: how to prevent dementia and keep our mind sharp as we age. A psychiatrist and international speaker, Jennings introduces his new book, recently rated #1 by Amazon in books on dementia, The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind.

Dr. Jennings prescribes simple, everyday actions we can take to stave off disease, promote vitality, and prevent dementia and late-onset Alzheimer's. "The choices we make now can help us to keep our minds sharp and maintain our independence as we age,” says Jennings.

An easy-to-use guide to maintaining brain and body health throughout life, The Aging Brain is based on solid, up-to-date scientific research, and the interventions discussed can prevent progression toward dementia, even in those already showing signs of mild cognitive impairment. The recommendations also may help reduce disability and depression.

"This book isn't just for people hoping to slow the aging process,” says Jennings. "It's also for anyone who is a caregiver to someone at risk of or already beginning to suffer from dementia. It offers a hopeful, healthy way forward.”

Jennings, who maintains a private practice in Chattanooga, TN, has authored several books, including The God-Shaped Brain and The God-Shaped Heart. He is a Distinguished Fellow of the American Psychiatric Association and Fellow of the Southern Psychiatric Association, and is president and founder of Come and Reason Ministries.

For more information about Dr. Jennings, please visit the website: https://www.agingbrainbook.com.

To connect with Dr. Jennings, please visit: https://www.facebook.com/DrTimJennings/ and https://twitter.com/timjenningsmd.

The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind
Baker Books
Released: June 2018
ISBN-10: 080107522X
ISBN-13: 978-0801075223

###

Reviews for The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind:

Dr. Caroline Leaf, Cognitive Neuroscientist, Communication Pathologist and Author: "Great advice and excellent science on aging! It's well worth following and applying these principles so as to age the way we are supposed to.”

Rodney A. Poling, MD, DFAPA, medical director, Behavioral Healthcare Center, Columbia TN., and board-certified geriatric psychiatrist: "A well-researched and commonsense book aimed at helping one understand the complexities of dementia, while offering recommendations for maintaining healthy brain function into our later years.”

Michael Lyles, psychiatrist, author, and speaker: "Dr. Jennings clearly describes how to practically manage the medical and lifestyle variables that can positively impact brain health and the process of aging. Age is a number, but getting old is a lifestyle.”

Sweat it Out: How to Increase Fat Loss during Your Workout

If you have been exercising for any length of time, you know how good regular movement is for your body. It can keep you feeling limber, give you more energy, improve your mood and lower your risk of many chronic health conditions. However, if you want to ensure that your workouts are specifically targeting extra fat that you have, try these four smart workout tips.

Try Strength Training

Muscle burns more calories than other tissues do. Therefore, it is in your best interest to focus plenty of your workout time on strength training each week. You can try using light weights with high reps, or you can choose to use very heavy weights to max yourself out in under eight reps. Both types of strength training can help you get lean without bulking up dramatically.

Try High Intensity Interval Training

High intensity interval training, or HIIT workouts, have been gaining in popularity over the past few years. Not only are they a fun new way to spice up your workout, but also they have been shown to be better at burning calories and fat off your body in a shorter amount of time than you would see with regular cardio. Try working out at your highest intensity for two minutes before leveling off for the third minute. Do this over and over throughout your workout time.

Try More Cardio Exercise Overall

Despite the benefits of HIIT workouts, it is still important for you to get in your regular cardio workouts as well. After every cardio workout, you continue to burn fat calories at an increased rate for several hours. You will notice that your metabolism is boosted. Therefore, it is important to raise your heart rate regularly several times every week. Even in cold weather, you can continue your outdoor cardio workouts when you wear warm running leggings and long sleeve performance shirts.

Exercise Hungry

Although this may initially make you feel quite uncomfortable, you can ensure that your body is using fat stores for energy if you exercise on an empty stomach. This is especially effective in the morning when you are sure that your body has burned through all of its food from the prior night. Go for a run or do your cardio workout first thing in the morning before having a protein-packed breakfast to get you ready for the rest of the day.

While anyone knows that weight loss occurs when you burn more calories than you take in, it is not always that easy to focus on fat loss, especially if you want to keep up your muscle mass. However, by focusing on smart strength training, using HIIT workouts frequently, amping up your cardio workouts, and knowing when to eat around your workout time, you can ensure that your body is working its hardest to burn through your unwanted fat stores. Slowly start integrating these changes into your regular workouts, and watch your body become lean and strong.